Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Liron Caplan

Concepts (359)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Spondylitis, Ankylosing
12
2024
43
5.470
Why?
Arthritis, Rheumatoid
52
2025
1184
4.680
Why?
Rheumatology
15
2023
136
3.980
Why?
Spondylarthritis
10
2024
50
3.810
Why?
Antirheumatic Agents
27
2019
309
3.360
Why?
Osteoporosis
10
2023
239
1.830
Why?
Glucocorticoids
11
2025
536
1.660
Why?
Severity of Illness Index
26
2023
2910
1.450
Why?
Health Literacy
5
2019
182
1.420
Why?
Anti-Inflammatory Agents, Non-Steroidal
5
2023
344
1.390
Why?
Gastrointestinal Diseases
3
2018
220
1.360
Why?
Methotrexate
11
2018
234
1.070
Why?
Arthritis
2
2019
97
1.030
Why?
Drug-Related Side Effects and Adverse Reactions
3
2015
266
1.000
Why?
Registries
21
2025
2382
0.910
Why?
Decision Support Systems, Management
2
2015
7
0.860
Why?
Community Health Workers
1
2025
89
0.830
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
2
2014
36
0.780
Why?
Sacroiliitis
1
2022
7
0.750
Why?
Fractures, Bone
3
2023
431
0.680
Why?
Cardiovascular Diseases
9
2023
2218
0.680
Why?
Bone Density Conservation Agents
4
2014
82
0.680
Why?
Veterans
14
2025
1647
0.670
Why?
Humans
102
2025
145625
0.650
Why?
Outpatient Clinics, Hospital
2
2011
80
0.630
Why?
Arthritis, Psoriatic
2
2023
15
0.630
Why?
Health Knowledge, Attitudes, Practice
4
2015
1403
0.630
Why?
Conflict of Interest
1
2020
52
0.610
Why?
Patient Readmission
1
2025
771
0.600
Why?
Body Mass Index
10
2018
2446
0.600
Why?
Transportation
1
2019
54
0.590
Why?
Drug Packaging
1
2019
41
0.590
Why?
Inflammatory Bowel Diseases
3
2018
352
0.570
Why?
Rheumatic Diseases
2
2018
101
0.560
Why?
Gastrointestinal Tract
2
2018
203
0.550
Why?
Visual Analog Scale
2
2019
33
0.550
Why?
Prednisone
6
2025
229
0.530
Why?
Antibodies, Antineutrophil Cytoplasmic
1
2018
31
0.530
Why?
Pharmaceutical Preparations
1
2019
172
0.530
Why?
United States
34
2025
16041
0.520
Why?
Vasculitis
1
2018
69
0.510
Why?
Joints
3
2013
107
0.510
Why?
Disability Evaluation
2
2018
297
0.510
Why?
Aged
45
2025
26251
0.510
Why?
Medication Therapy Management
1
2018
73
0.500
Why?
Diphosphonates
3
2014
67
0.480
Why?
Tumor Necrosis Factor-alpha
8
2022
1223
0.480
Why?
Middle Aged
49
2025
36359
0.480
Why?
Chemical and Drug Induced Liver Injury
1
2018
138
0.480
Why?
Health Care Costs
1
2019
418
0.440
Why?
Cross-Sectional Studies
16
2019
5875
0.440
Why?
Patient Satisfaction
2
2019
698
0.430
Why?
Male
58
2025
73014
0.430
Why?
Patient Education as Topic
4
2015
769
0.430
Why?
Liver Diseases
1
2018
298
0.430
Why?
Randomized Controlled Trials as Topic
5
2025
1754
0.420
Why?
Practice Patterns, Physicians'
3
2015
1370
0.410
Why?
Surveys and Questionnaires
7
2016
6050
0.410
Why?
gamma-Glutamyl Hydrolase
1
2014
3
0.410
Why?
Peptide Synthases
1
2014
4
0.410
Why?
Veterans Health
5
2017
188
0.410
Why?
Diabetes Mellitus, Type 2
4
2022
2623
0.400
Why?
Weight Loss
5
2018
857
0.400
Why?
Attitude of Health Personnel
2
2013
1212
0.400
Why?
Proteins
1
2019
1021
0.390
Why?
Spondylarthropathies
3
2019
5
0.390
Why?
Health Status
3
2018
822
0.380
Why?
Risk Factors
24
2023
10840
0.370
Why?
Protein Kinase Inhibitors
1
2019
982
0.370
Why?
Arthroplasty, Replacement, Hip
1
2015
187
0.370
Why?
Societies, Medical
5
2019
901
0.370
Why?
Biomedical Research
1
2019
724
0.370
Why?
Symptom Assessment
1
2013
137
0.370
Why?
Consumer Behavior
1
2013
68
0.360
Why?
Female
51
2025
79080
0.360
Why?
Activities of Daily Living
1
2016
438
0.360
Why?
Folic Acid
1
2014
197
0.360
Why?
Lipids
2
2014
715
0.360
Why?
Pharmacists
1
2015
260
0.350
Why?
Physical Therapy Modalities
1
2015
341
0.350
Why?
Patient Reported Outcome Measures
1
2016
502
0.340
Why?
Hospitals, Public
1
2011
30
0.340
Why?
Health Personnel
3
2014
750
0.340
Why?
Obesity
5
2018
3123
0.340
Why?
Pain
2
2022
787
0.330
Why?
Electronic Health Records
3
2015
1208
0.330
Why?
Anti-Inflammatory Agents
4
2018
473
0.300
Why?
Autoantibodies
5
2019
1498
0.300
Why?
Telemedicine
1
2019
956
0.290
Why?
Efficiency, Organizational
1
2010
142
0.290
Why?
Cerebrovascular Disorders
3
1997
103
0.290
Why?
Linear Models
5
2019
847
0.280
Why?
Adalimumab
4
2020
53
0.280
Why?
Workflow
1
2010
181
0.280
Why?
Musculoskeletal Diseases
1
2010
94
0.280
Why?
Physician-Patient Relations
2
2011
595
0.280
Why?
Publications
1
2008
47
0.270
Why?
Practice Guidelines as Topic
5
2018
1581
0.260
Why?
CARD Signaling Adaptor Proteins
2
2024
22
0.260
Why?
Ethics, Medical
1
2008
90
0.260
Why?
Patient Compliance
1
2012
587
0.260
Why?
Etanercept
3
2016
60
0.250
Why?
United States Department of Veterans Affairs
8
2016
777
0.250
Why?
Observational Studies as Topic
2
2025
133
0.250
Why?
Radiography
3
2019
856
0.240
Why?
Infliximab
3
2016
107
0.240
Why?
Diabetes Mellitus
1
2015
1101
0.240
Why?
Time Factors
12
2018
7079
0.230
Why?
Aged, 80 and over
11
2019
8351
0.230
Why?
Adult
20
2023
40821
0.230
Why?
Drug Utilization
3
2018
170
0.220
Why?
Professional Practice
1
2005
58
0.220
Why?
Ambulatory Care
1
2010
627
0.220
Why?
Treatment Outcome
13
2019
11744
0.220
Why?
Peptides, Cyclic
4
2016
276
0.210
Why?
Longitudinal Studies
9
2019
3005
0.200
Why?
HLA-B27 Antigen
2
2024
16
0.200
Why?
Adrenal Cortex Hormones
1
2007
483
0.200
Why?
Reproducibility of Results
5
2016
3396
0.200
Why?
Rheumatoid Factor
3
2016
177
0.200
Why?
Polymorphism, Single Nucleotide
4
2019
2228
0.190
Why?
Quality of Life
1
2016
3187
0.190
Why?
Evidence-Based Medicine
2
2018
727
0.190
Why?
Dose-Response Relationship, Drug
5
2014
2018
0.190
Why?
Cohort Studies
11
2015
6045
0.190
Why?
Bone Density
4
2023
492
0.190
Why?
Predictive Value of Tests
5
2018
2097
0.190
Why?
Magnetic Resonance Imaging
4
2025
3917
0.180
Why?
Myocardial Infarction
3
2018
1212
0.180
Why?
Retrospective Studies
11
2022
17291
0.170
Why?
Inflammation
4
2018
2915
0.170
Why?
Biomarkers
5
2022
4329
0.160
Why?
Lymphocytes
1
2022
379
0.160
Why?
Self Report
1
2025
869
0.160
Why?
Multivariate Analysis
8
2018
1531
0.160
Why?
Prognosis
6
2016
4331
0.160
Why?
C-Reactive Protein
3
2017
427
0.160
Why?
Proportional Hazards Models
6
2016
1318
0.160
Why?
Neutrophils
2
2024
1132
0.160
Why?
Granuloma, Foreign-Body
1
2020
8
0.150
Why?
Regression Analysis
3
2011
994
0.150
Why?
Risk Assessment
7
2018
3678
0.150
Why?
Tattooing
1
2020
14
0.150
Why?
Genetic Predisposition to Disease
5
2024
2455
0.150
Why?
Genotype
3
2014
1866
0.150
Why?
Comorbidity
6
2018
1652
0.150
Why?
Malondialdehyde
1
2019
31
0.150
Why?
Acetaldehyde
1
2019
17
0.150
Why?
Macular Edema
1
2020
49
0.150
Why?
Blood Platelets
1
2022
380
0.150
Why?
Drug Stability
1
2019
168
0.150
Why?
Protein Stability
1
2019
175
0.140
Why?
Biosimilar Pharmaceuticals
1
2019
28
0.140
Why?
Drug Compounding
1
2019
106
0.140
Why?
Deprescriptions
1
2019
38
0.140
Why?
Drug Monitoring
2
2012
399
0.140
Why?
Metformin
1
2022
328
0.140
Why?
Intraepithelial Lymphocytes
1
2018
17
0.140
Why?
Uveitis
1
2020
151
0.140
Why?
Vertebrobasilar Insufficiency
1
1998
9
0.140
Why?
Pyrroles
1
2019
221
0.130
Why?
Hydroxychloroquine
2
2018
65
0.130
Why?
Blood Glucose
4
2022
2357
0.130
Why?
Cerebral Infarction
1
1998
46
0.130
Why?
Clinical Trials as Topic
2
2022
1062
0.130
Why?
Mesencephalon
1
1998
65
0.130
Why?
Piperidines
1
2019
223
0.130
Why?
Stress, Mechanical
1
2019
493
0.130
Why?
Obesity, Abdominal
1
2017
48
0.130
Why?
Inflammation Mediators
2
2017
507
0.130
Why?
Remission Induction
3
2012
308
0.120
Why?
Temperature
1
2019
633
0.120
Why?
Absorptiometry, Photon
3
2017
276
0.120
Why?
Drug Administration Schedule
2
2010
782
0.120
Why?
Thrombolytic Therapy
1
1997
165
0.120
Why?
Sodium Chloride
1
2016
138
0.120
Why?
Biological Products
1
2019
257
0.120
Why?
Research Design
1
2022
1139
0.110
Why?
Pyrimidines
1
2019
530
0.110
Why?
Tissue Plasminogen Activator
1
1997
244
0.110
Why?
Administration, Oral
2
2025
867
0.110
Why?
Genes, rel
1
2014
4
0.110
Why?
Patient Selection
3
2022
720
0.100
Why?
DNA Methylation
1
2019
721
0.100
Why?
Lipoproteins, LDL
1
2014
119
0.100
Why?
Lipoproteins, HDL
1
2014
104
0.100
Why?
Hand
1
2015
156
0.100
Why?
Disease Management
1
2018
649
0.100
Why?
Vascular Calcification
1
2015
109
0.100
Why?
Diagnosis, Differential
1
2018
1500
0.100
Why?
Antibodies, Monoclonal, Humanized
1
2019
992
0.100
Why?
Incidence
7
2018
2910
0.090
Why?
Femoral Fractures
1
2014
84
0.090
Why?
Spinal Fractures
1
2014
81
0.090
Why?
Adiposity
1
2017
531
0.090
Why?
Immunosuppressive Agents
3
2009
824
0.090
Why?
Algorithms
2
2025
1843
0.090
Why?
Lung Diseases, Interstitial
1
2019
677
0.090
Why?
Health Services Research
1
2015
389
0.090
Why?
North America
1
2013
299
0.090
Why?
Dyslipidemias
1
2014
184
0.090
Why?
Immunoglobulin G
1
2016
899
0.090
Why?
Chronic Disease
2
2018
1824
0.090
Why?
Insurance, Pharmaceutical Services
1
2011
23
0.090
Why?
Polymorphism, Genetic
2
2011
611
0.090
Why?
Triglycerides
1
2014
527
0.090
Why?
Autoimmunity
1
2018
924
0.090
Why?
Lung Diseases
1
2018
787
0.090
Why?
Coronary Artery Disease
1
2018
751
0.080
Why?
Lipopolysaccharide Receptors
1
2011
88
0.080
Why?
Antibodies, Monoclonal
2
2016
1511
0.080
Why?
Glutathione Transferase
1
2010
92
0.080
Why?
Memory Disorders
1
2012
197
0.080
Why?
Nanoparticles
1
2016
521
0.080
Why?
Gastrointestinal Microbiome
1
2018
767
0.080
Why?
Health Care Surveys
1
2012
538
0.080
Why?
Workload
1
2012
169
0.080
Why?
HLA-DR Antigens
1
2010
211
0.080
Why?
Young Adult
3
2019
14240
0.070
Why?
Sex Factors
4
2017
2101
0.070
Why?
Hypertension
1
2018
1270
0.070
Why?
Follow-Up Studies
4
2015
5397
0.070
Why?
Health Surveys
2
2012
511
0.070
Why?
Hip Fractures
1
2010
88
0.070
Why?
Immunocompromised Host
2
2011
201
0.070
Why?
Disease Progression
4
2019
2857
0.070
Why?
Cytokines
1
2016
2079
0.070
Why?
Epitopes
1
2010
479
0.070
Why?
Databases, Bibliographic
1
2008
30
0.070
Why?
Vitamin D Deficiency
1
2010
188
0.070
Why?
Beneficence
1
2008
20
0.070
Why?
Pilot Projects
1
2014
1878
0.070
Why?
Self Care
1
2011
396
0.070
Why?
Hospitalization
2
2011
2468
0.070
Why?
Awards and Prizes
1
1989
72
0.070
Why?
Sensitivity and Specificity
1
2013
1992
0.070
Why?
Drug Prescriptions
1
2010
290
0.070
Why?
Interviews as Topic
1
2012
926
0.070
Why?
Prospective Studies
4
2013
8087
0.060
Why?
Social Justice
1
2008
82
0.060
Why?
Research Personnel
1
1989
189
0.060
Why?
Neoplasms
3
2017
2944
0.060
Why?
Urban Population
1
2010
496
0.060
Why?
Self Administration
1
2007
121
0.060
Why?
Depressive Disorder
1
2009
359
0.060
Why?
Infusions, Intravenous
2
2016
429
0.060
Why?
Carcinoma, Squamous Cell
1
2011
627
0.060
Why?
Quality of Health Care
1
2011
692
0.060
Why?
Herpes Zoster
1
2009
318
0.060
Why?
Age Factors
4
2015
3321
0.060
Why?
Respiratory Tract Diseases
2
2017
178
0.050
Why?
Military Personnel
1
2013
715
0.050
Why?
Stress Disorders, Post-Traumatic
1
2013
889
0.050
Why?
Cause of Death
2
2017
455
0.050
Why?
Qualitative Research
1
2012
1720
0.050
Why?
Skin Neoplasms
1
2011
805
0.050
Why?
Spine
1
2025
184
0.050
Why?
Coculture Techniques
1
2024
244
0.050
Why?
Immunity, Innate
2
2024
843
0.050
Why?
Interleukin-17
1
2024
121
0.050
Why?
Databases, Factual
3
2014
1481
0.050
Why?
Survival Analysis
2
2018
1372
0.050
Why?
Th17 Cells
1
2024
103
0.050
Why?
Autoantigens
2
2019
426
0.050
Why?
Antibody Formation
2
2019
290
0.050
Why?
Isoxazoles
2
2016
56
0.040
Why?
Adolescent
3
2019
22451
0.040
Why?
Intracellular Signaling Peptides and Proteins
1
2004
456
0.040
Why?
Case-Control Studies
2
2019
3633
0.040
Why?
Carrier Proteins
1
2004
728
0.040
Why?
Pneumonia
1
2006
633
0.040
Why?
Foreign-Body Reaction
1
2020
34
0.040
Why?
Prevalence
1
2007
2852
0.040
Why?
Phospholipase D
1
2019
7
0.040
Why?
Steroids
1
2020
160
0.040
Why?
Sulfasalazine
1
2018
22
0.030
Why?
Intracranial Embolism and Thrombosis
1
1998
7
0.030
Why?
New England
1
1998
37
0.030
Why?
Microtubule-Associated Proteins
1
2019
184
0.030
Why?
Coronary Thrombosis
1
1998
25
0.030
Why?
Blood Sedimentation
1
2017
37
0.030
Why?
Infusions, Intra-Arterial
1
1997
61
0.030
Why?
Vulnerable Populations
1
2019
177
0.030
Why?
Child
3
2023
22638
0.030
Why?
Molecular Chaperones
1
2019
200
0.030
Why?
RNA, Long Noncoding
1
2019
173
0.030
Why?
Rheumatic Nodule
1
2016
3
0.030
Why?
Mitochondrial Proteins
1
2019
263
0.030
Why?
Consensus
1
2018
465
0.030
Why?
Osteoarthritis
1
2019
204
0.030
Why?
Visual Acuity
1
2020
497
0.030
Why?
Adsorption
1
2016
154
0.030
Why?
Biopsy
1
2020
1073
0.030
Why?
Machine Learning
1
2022
590
0.030
Why?
Nutrition Surveys
1
2017
270
0.030
Why?
Thinness
1
2016
99
0.030
Why?
Drug Substitution
1
2016
62
0.030
Why?
Administration, Intravenous
1
2016
172
0.030
Why?
Protein Aggregates
1
2016
87
0.030
Why?
T-Lymphocytes
1
2004
2007
0.030
Why?
Chemokines
1
2016
217
0.030
Why?
Particle Size
1
2016
382
0.030
Why?
Cerebrovascular Circulation
1
1998
293
0.030
Why?
Mortality
1
2018
375
0.030
Why?
Apolipoproteins E
1
2015
97
0.030
Why?
Lymphoma
1
2016
251
0.030
Why?
Interleukin-4
1
2015
207
0.030
Why?
Epigenesis, Genetic
1
2019
705
0.030
Why?
Leukemia
1
2016
246
0.030
Why?
Antigen-Antibody Complex
1
2014
70
0.030
Why?
Cardiac Catheterization
1
2018
569
0.030
Why?
Hospitals, Veterans
1
2015
256
0.020
Why?
United States Food and Drug Administration
1
2014
207
0.020
Why?
Causality
1
2014
128
0.020
Why?
Life Style
1
2016
495
0.020
Why?
Mutation
1
2024
4082
0.020
Why?
Hypoglycemic Agents
1
2022
1411
0.020
Why?
Body Weight
1
2016
964
0.020
Why?
Genome-Wide Association Study
1
2019
1526
0.020
Why?
Blood Pressure
1
2018
1761
0.020
Why?
Data Mining
1
2011
113
0.020
Why?
Survival Rate
1
2015
2078
0.020
Why?
HLA-DRB1 Chains
1
2010
109
0.020
Why?
Logistic Models
1
2015
2112
0.020
Why?
Propensity Score
1
2011
370
0.020
Why?
Mice
2
2024
18266
0.020
Why?
Smoking
1
2016
1478
0.020
Why?
Prostatic Neoplasms
1
2016
972
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2010
845
0.020
Why?
Medication Adherence
1
2012
535
0.020
Why?
Risk
1
2011
917
0.020
Why?
Pancreatic Neoplasms
1
2016
944
0.020
Why?
Polymerase Chain Reaction
1
2010
1030
0.020
Why?
Congresses as Topic
1
1989
226
0.020
Why?
Tomography, X-Ray Computed
1
1997
2766
0.020
Why?
American Heart Association
1
1989
363
0.020
Why?
Periodicals as Topic
1
1989
209
0.010
Why?
Lung
1
2019
4119
0.010
Why?
Population Surveillance
1
2009
477
0.010
Why?
Signaling Lymphocytic Activation Molecule Associated Protein
1
2004
1
0.010
Why?
Signaling Lymphocytic Activation Molecule Family Member 1
1
2004
2
0.010
Why?
Lupus Vulgaris
1
2004
5
0.010
Why?
Socioeconomic Factors
1
2009
1323
0.010
Why?
Animals
2
2024
38030
0.010
Why?
Encephalomyelitis, Autoimmune, Experimental
1
2004
66
0.010
Why?
Immunoglobulins
1
2004
162
0.010
Why?
Lung Neoplasms
1
2016
2674
0.010
Why?
Forecasting
1
2004
386
0.010
Why?
Glycoproteins
1
2004
355
0.010
Why?
Receptors, Cell Surface
1
2004
371
0.010
Why?
Drug Therapy, Combination
1
2004
1034
0.010
Why?
Mice, Inbred BALB C
1
2004
1244
0.010
Why?
Antigens, CD
1
2004
559
0.010
Why?
Cell Membrane
1
2004
701
0.010
Why?
Autoimmune Diseases
1
2004
466
0.010
Why?
Mice, Knockout
1
2004
3121
0.010
Why?
Disease Models, Animal
1
2004
4565
0.010
Why?
Mice, Inbred C57BL
1
2004
6021
0.010
Why?
Signal Transduction
1
2004
5234
0.000
Why?
Caplan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)